Long-term outcomes of patients with metastatic gastric cancer after initial S-1 monotherapy

被引：0
|
作者：
Ayumu Hosokawa
Toshiro Sugiyama
Atsushi Ohtsu
Toshihiko Doi
Santa Hattori
Takashi Kojima
Tomonori Yano
Keiko Minashi
Manabu Muto
Shigeaki Yoshida
机构：
[1] University of Toyama,Department of Internal Medicine, Faculty of Medicine
[2] National Cancer Center Hospital East,Division of Gastrointestinal Oncology and Digestive Endoscopy
来源：
Journal of Gastroenterology | 2007年 / 42卷
关键词：
gastric cancer; chemotherapy; S-1; clinical practice;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：533 / 538
页数：5
相关论文
共 50 条
  • [1] Long-term outcomes of patients with metastatic gastric cancer after initial S-1 monotherapy
    Hosokawa, Ayumu
    Sugiyama, Toshiro
    Ohtsu, Atsushi
    Doi, Toshihiko
    Hattori, Santa
    Kojima, Takashi
    Yano, Tomonori
    Minashi, Keiko
    Muto, Manabu
    Yoshida, Shigeaki
    JOURNAL OF GASTROENTEROLOGY, 2007, 42 (07) : 533 - 538
  • [2] Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer
    Kasahara, Kohei
    Kunisaki, Chikara
    Sato, Sho
    Kondo, Hiroki
    Takahashi, Masazumi
    Tamura, Yuko
    Tsuchiya, Nobuhiro
    Tanaka, Yusaku
    Sato, Kei
    Kimura, Jun
    Kosaka, Takashi
    Ono, Hidetaka
    Makino, Hirochika
    Akiyama, Hirotoshi
    Endo, Itaru
    ANTICANCER RESEARCH, 2023, 43 (06) : 2841 - 2850
  • [3] Pharmacokinetics of S-1 monotherapy in plasma and in tears for gastric cancer patients
    Yasui, Hirofumi
    Kawakami, Takeshi
    Kashiwagi, Hiroya
    Mori, Keita
    Omae, Katsuhiro
    Kasai, Jun
    Yoshisue, Kunihiro
    Kawahira, Masahiro
    Tsushima, Takahiro
    Machida, Nozomu
    Fukutomi, Akira
    Yamaguchi, Ken
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (06) : 660 - 665
  • [4] Pharmacokinetics of S-1 monotherapy in plasma and in tears for gastric cancer patients
    Hirofumi Yasui
    Takeshi Kawakami
    Hiroya Kashiwagi
    Keita Mori
    Katsuhiro Omae
    Jun Kasai
    Kunihiro Yoshisue
    Masahiro Kawahira
    Takahiro Tsushima
    Nozomu Machida
    Akira Fukutomi
    Ken Yamaguchi
    International Journal of Clinical Oncology, 2019, 24 : 660 - 665
  • [5] S-1 monotherapy for the treatment of elderly patients with advanced gastric cancer
    Lim, J.
    Kim, J.
    Yi, H.
    Kim, H.
    Lee, M.
    Kim, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer
    Sakaguchi Y.
    Kabashima A.
    Okita K.
    Ojima Y.
    Yamamura S.
    Nishizaki T.
    Tashiro H.
    Matsusaka T.
    Gastric Cancer, 2005, 8 (2) : 111 - 116
  • [7] S-1 COMBINATION CHEMOTHERAPY IS SUPERIOR TO S-1 MONOTHERAPY FOR UNRESECTABLE ADVANCED GASTRIC CANCER IN AGED PATIENTS
    Miura, Tomofumi
    Nakamura, Junichiro
    Yamada, Satoshi
    Nakazawa, Yasuko
    Ozeki, Yutaka
    Miura, Tsutomu
    Yanagi, Masahiko
    Takahashi, Toru
    ANNALS OF ONCOLOGY, 2010, 21 : 28 - 28
  • [8] Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer
    Takahiro Tsushima
    Shuichi Hironaka
    Narikazu Boku
    Nozomu Machida
    Kentaro Yamazaki
    Hirofumi Yasui
    Keisei Taku
    Akira Fukutomi
    Yusuke Onozawa
    Gastric Cancer, 2010, 13 : 245 - 250
  • [9] Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer
    Tsushima, Takahiro
    Hironaka, Shuichi
    Boku, Narikazu
    Machida, Nozomu
    Yamazaki, Kentaro
    Yasui, Hirofumi
    Taku, Keisei
    Fukutomi, Akira
    Onozawa, Yusuke
    GASTRIC CANCER, 2010, 13 (04) : 245 - 250
  • [10] Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer Long-term Outcomes From a Phase 1 Study
    Petrylak, Daniel P.
    Powles, Thomas
    Bellmunt, Joaquim
    Braiteh, Fadi
    Luriot, Yohann
    Murales-Barrera, Rafael
    Burris, Howard A.
    Kim, Joseph W.
    Ding, Beiying
    Kaiser, Constanze
    Fasso, Marcella
    O'Hear, Carol
    Vogelzang, Nicholas J.
    JAMA ONCOLOGY, 2018, 4 (04) : 537 - 544
12345